Functional expression of human-epidermal-growth-factor receptor in a melanoma cell line

被引:6
作者
Diaz, Arlhee [1 ]
Suarez, Eduardo [1 ]
Blanco, Rances [1 ]
Badia, Teresita [1 ]
Rivero, Dianelys [1 ]
Lopez-Requena, Alejandro [1 ]
Lopez, Armando [1 ]
Montero, Enrique [1 ]
机构
[1] Ctr Mol Immunol, Dept Expt Immunotherapy, Havana 11600, Cuba
关键词
cytoloxicity; epidermal-growth-factor receptor (EGFR); flow cytometry; melanoma; overexpression; proliferation;
D O I
10.1042/BA20070009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
EGFR [EGF (epidermal growth factor) receptor] over- expression correlates with poor prognosis and bad outcomes in different tumours. However, evidence for EGFR contribution in melanoma immunobiology is limited. We have expressed the full-length human EGFR gene in a murine melanoma cell line. EGFR protein expression in stably trnasfected B 16 cells in culture was defined by immunoblotting, immunohistochemistry and FACS. Additionally, transfected cells became sensitive to the lysis induced with an anti-EGFR monoclonal antibody in the presence of complement. Exogenous human EGF addition induced cell proliferation, validating the transfected receptor functionality. Thus we have developed a system to express a functional EGFR in order to evaluate the potential contribution of EGFR expression in melanoma biology and its resulting relevance as a target for immunointerventions in nonepithelial tumours.
引用
收藏
页码:21 / 27
页数:7
相关论文
共 29 条
  • [1] Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation
    Brandt, R
    Eisenbrandt, R
    Leenders, F
    Zschiesche, W
    Binas, B
    Juergensen, C
    Theuring, F
    [J]. ONCOGENE, 2000, 19 (17) : 2129 - 2137
  • [2] Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-α in head and neck cancer cells in vitro and in vivo
    Bruzzese, F
    Di Gennaro, E
    Avallone, A
    Pepe, S
    Arra, C
    Caraglia, M
    Tagliaferri, P
    Budillon, A
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (02) : 617 - 625
  • [3] RECEPTORS FOR EPIDERMAL GROWTH-FACTOR AND OTHER POLYPEPTIDE MITOGENS
    CARPENTER, G
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 : 881 - 914
  • [4] Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor
    Crombet, T
    Torres, O
    Neninger, E
    Catalá, M
    Rodríguez, N
    Ramos, M
    Fernández, E
    Iznaga, N
    Pérez, R
    Lage, A
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (01) : 93 - 102
  • [5] De Jong JS, 1998, J PATHOL, V184, P53, DOI 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO
  • [6] 2-7
  • [7] DEWIT PE, 1999, J INVEST DERMATOL, V99, P168
  • [8] OVEREXPRESSION OF THE HUMAN EGF RECEPTOR CONFERS AN EGF-DEPENDENT TRANSFORMED PHENOTYPE TO NIH 3T3 CELLS
    DIFIORE, PP
    PIERCE, JH
    FLEMING, TP
    HAZAN, R
    ULLRICH, A
    KING, CR
    SCHLESSINGER, J
    AARONSON, SA
    [J]. CELL, 1987, 51 (06) : 1063 - 1070
  • [9] A NEW MONOCLONAL-ANTIBODY FOR DETECTION OF EGF-RECEPTORS IN WESTERN BLOTS AND PARAFFIN-EMBEDDED TISSUE-SECTIONS
    FERNANDEZ, A
    SPITZER, E
    PEREZ, R
    BOEHMER, FD
    ECKERT, K
    ZSCHIESCHE, W
    GROSSE, R
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1992, 49 (02) : 157 - 165
  • [10] GLEAVE ME, 1993, CANCER RES, V53, P5300